{
    "clinical_study": {
        "@rank": "159799", 
        "acronym": "ODYSSEY OLE", 
        "arm_group": {
            "arm_group_label": "Alirocumab", 
            "arm_group_type": "Experimental", 
            "description": "Injection through subcutaneous (SC) administration"
        }, 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To assess the long-term safety of alirocumab when added to lipid-lowering therapy in\n      patients with heterozygous familial hypercholesterolemia (heFH).\n\n      Secondary Objectives:\n\n      To evaluate the long-term efficacy of alirocumab on lipid parameters. To evaluate the\n      long-term immunogenicity of alirocumab."
        }, 
        "brief_title": "Open Label Study of Long Term Safety Evaluation of Alirocumab", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypercholesterolemia", 
        "condition_browse": {
            "mesh_term": [
                "Hypercholesterolemia", 
                "Hyperlipoproteinemia Type II"
            ]
        }, 
        "detailed_description": {
            "textblock": "The maximum study duration will be 120 weeks per patient."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        Patients with heFH who have completed one of the four parent studies (EFC12492,\n        R727-CL-1112, EFC12732 and LTS11717).\n\n        Exclusion criteria:\n\n        Significant protocol deviation in the parent study; Any permanent treatment\n        discontinuation from the parent study.\n\n        The above information is not intended to contain all considerations relevant to a\n        patient's potential participation in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01954394", 
            "org_study_id": "LTS13463", 
            "secondary_id": [
                "2013-002572-40", 
                "U1111-1143-3810"
            ]
        }, 
        "intervention": {
            "arm_group_label": "Alirocumab", 
            "description": "Pharmaceutical form:Solution for injection Route of administration: Subcutaneous", 
            "intervention_name": "Alirocumab SAR236553 (REGN727)", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35801"
                    }, 
                    "name": "Investigational Site Number 840321"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bell Gardens", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90201"
                    }, 
                    "name": "Investigational Site Number 840334"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92663"
                    }, 
                    "name": "Investigational Site Number 840337"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Golden", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80401"
                    }, 
                    "name": "Investigational Site Number 840306"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ft. Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33308"
                    }, 
                    "name": "Investigational Site Number 840318"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32216"
                    }, 
                    "name": "Investigational Site Number 840327"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }, 
                    "name": "Investigational Site Number 840329"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auburn", 
                        "country": "United States", 
                        "state": "Maine", 
                        "zip": "04210"
                    }, 
                    "name": "Investigational Site Number 840345"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28207"
                    }, 
                    "name": "Investigational Site Number 840303"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45227"
                    }, 
                    "name": "Investigational Site Number 840340"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76104"
                    }, 
                    "name": "Investigational Site Number 840301"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bountiful", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84010"
                    }, 
                    "name": "Investigational Site Number 840343"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec", 
                        "country": "Canada", 
                        "zip": "G1V 4M6"
                    }, 
                    "name": "Investigational Site Number 124301"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21000"
                    }, 
                    "name": "Investigational Site Number 250303"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037 Cedex"
                    }, 
                    "name": "Investigational Site Number 250304"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes Cedex 01", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Investigational Site Number 250302"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Investigational Site Number 250301"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy", 
                        "zip": "90127"
                    }, 
                    "name": "Investigational Site Number 380301"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam-Zuidoost", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Investigational Site Number 528301"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands", 
                        "zip": "5616GB"
                    }, 
                    "name": "Investigational Site Number 528313"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hoorn", 
                        "country": "Netherlands", 
                        "zip": "1625 HV"
                    }, 
                    "name": "Investigational Site Number 528318"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3021 HC"
                    }, 
                    "name": "Investigational Site Number 528315"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zoetermeer", 
                        "country": "Netherlands", 
                        "zip": "2724 EK"
                    }, 
                    "name": "Investigational Site Number 528327"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cap Town", 
                        "country": "South Africa", 
                        "zip": "7530"
                    }, 
                    "name": "Investigational Site Number 710311"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "zip": "7925"
                    }, 
                    "name": "Investigational Site Number 710302"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meyerspark", 
                        "country": "South Africa", 
                        "zip": "0184"
                    }, 
                    "name": "Investigational Site Number 710314"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parktown", 
                        "country": "South Africa", 
                        "zip": "2193"
                    }, 
                    "name": "Investigational Site Number 710312"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pretoria", 
                        "country": "South Africa", 
                        "zip": "0084"
                    }, 
                    "name": "Investigational Site Number 710303"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roodepoort", 
                        "country": "South Africa", 
                        "zip": "1724"
                    }, 
                    "name": "Investigational Site Number 710315"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Witbank", 
                        "country": "South Africa"
                    }, 
                    "name": "Investigational Site Number 710308"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sabadell", 
                        "country": "Spain", 
                        "zip": "08208"
                    }, 
                    "name": "Investigational Site Number 724310"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tarragona", 
                        "country": "Spain", 
                        "zip": "43204"
                    }, 
                    "name": "Investigational Site Number 724304"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middlesex", 
                        "country": "United Kingdom", 
                        "zip": "HA6 2RN"
                    }, 
                    "name": "Investigational Site Number 826305"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "France", 
                "Italy", 
                "Netherlands", 
                "South Africa", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732 and LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia", 
        "overall_contact": {
            "email": "Contact-Us@sanofi.com", 
            "last_name": "For site information, send an email with site number to"
        }, 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Assessment of safety parameters (adverse events, laboratory data, vital signs)", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 120 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01954394"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Percent change from baseline in low density lipoprotein cholesterol (LDL-C)", 
                "safety_issue": "No", 
                "time_frame": "Up to 120 weeks"
            }, 
            {
                "measure": "Percent change from baseline in other lipid parameters", 
                "safety_issue": "No", 
                "time_frame": "Up to 120 weeks"
            }
        ], 
        "source": "Sanofi", 
        "sponsors": {
            "collaborator": {
                "agency": "Regeneron Pharmaceuticals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}